BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 9391166)

  • 1. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor.
    Gehm BD; McAndrews JM; Chien PY; Jameson JL
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14138-43. PubMed ID: 9391166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
    Wietzke JA; Welsh J
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogenic activity in white and red wine extracts.
    Klinge CM; Risinger KE; Watts MB; Beck V; Eder R; Jungbauer A
    J Agric Food Chem; 2003 Mar; 51(7):1850-7. PubMed ID: 12643641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic compounds of wine: the phytoestrogen resveratrol and moderate red wine consumption during menopause.
    Calabrese G
    Drugs Exp Clin Res; 1999; 25(2-3):111-4. PubMed ID: 10370872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoid effects relevant to cancer.
    Brownson DM; Azios NG; Fuqua BK; Dharmawardhane SF; Mabry TJ
    J Nutr; 2002 Nov; 132(11 Suppl):3482S-3489S. PubMed ID: 12421874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
    Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
    Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.
    Wallerath T; Deckert G; Ternes T; Anderson H; Li H; Witte K; Förstermann U
    Circulation; 2002 Sep; 106(13):1652-8. PubMed ID: 12270858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
    Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
    Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture.
    Zava DT; Blen M; Duwe G
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):637-45. PubMed ID: 9168008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues.
    Schmitt E; Dekant W; Stopper H
    Toxicol In Vitro; 2001; 15(4-5):433-9. PubMed ID: 11566575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
    Collins-Burow BM; Burow ME; Duong BN; McLachlan JA
    Nutr Cancer; 2000; 38(2):229-44. PubMed ID: 11525602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP; Pezzuto JM
    Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha.
    Levenson AS; Gehm BD; Pearce ST; Horiguchi J; Simons LA; Ward JE; Jameson JL; Jordan VC
    Int J Cancer; 2003 May; 104(5):587-96. PubMed ID: 12594813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line.
    Stahl S; Chun TY; Gray WG
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):41-8. PubMed ID: 9772198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol.
    Basly JP; Marre-Fournier F; Le Bail JC; Habrioux G; Chulia AJ
    Life Sci; 2000 Jan; 66(9):769-77. PubMed ID: 10698352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol and red wine consumption.
    Slater I; Odum J; Ashby J
    Hum Exp Toxicol; 1999 Oct; 18(10):625-6. PubMed ID: 10557014
    [No Abstract]   [Full Text] [Related]  

  • 17. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
    Zava DT; Duwe G
    Nutr Cancer; 1997; 27(1):31-40. PubMed ID: 8970179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogenic activity of naturally occurring anthocyanidins.
    Schmitt E; Stopper H
    Nutr Cancer; 2001; 41(1-2):145-9. PubMed ID: 12094617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2.
    Gehm BD; Levenson AS; Liu H; Lee EJ; Amundsen BM; Cushman M; Jordan VC; Jameson JL
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):223-34. PubMed ID: 15120416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells.
    Tamir S; Eizenberg M; Somjen D; Stern N; Shelach R; Kaye A; Vaya J
    Cancer Res; 2000 Oct; 60(20):5704-9. PubMed ID: 11059763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.